Breaking News

CROnos Appoints Scientific VP

April 3, 2014

Engelhardt brings 20 years of experience

Dr. Nina Engelhardt has been appointed vice president of Scientific Innovation at CROnos Clinical Consulting. Dr. Engelhardt has more than 20 years of experience with trial methodology and clinical assessment aimed at increasing the success rate of placebo-controlled CNS trials.
Prior to joining the company, Dr. Engelhardt served as senior clinical trainer and research scientist for MedAvante and senior therapeutic area associate for new antidepressants at Eli Lilly. She has also served as a clinical research associate in the division of Clinical Psychopharmacology, at Tufts-New England Medical Center.
"Nina is an exciting addition to our clinical team.  We look forward to tapping into her expertise to deliver an improved product to our customers," said Guillermo Di Clemente, president and founder, CROnos. "Her diverse experience provides an outstanding view of our market and its current and future innovations."
  • Packaging Equipment Technology Preview

    Packaging Equipment Technology Preview

    February 15, 2017
    Today’s complex drug products present challenges; the latest equipment capabilities help overcome them

  • The Good, the Bad, and the Donald

    The Good, the Bad, and the Donald

    January 31, 2017
    Orphan drugs, CMO continuous manufacturing and developing world sales offer biggest revenue opportunities

  • Predictive Analytics and the Future of RBM

    Rajneesh Patil, Senior Director, RBM and Analytics, QuintilesIMS||January 23, 2017
    How advances in Risk-Based Monitoring will enable a more proactive approach to identify and mitigate potential risks